PROSECCO Trial: Cemiplimab Combination for Melanoma

ClinicalTrials.gov registered a new Phase III trial (NCT07511036) called PROSECCO, studying cemiplimab in combination therapy for melanoma. The trial is sponsored by Regeneron Pharmaceuticals and is currently listed as not recruiting. Cemiplimab is a PD-1 inhibitor marketed as Libtayo.

Clinical trial page for NCT07511049

Clinical trial page for NCT07511049

MEND II mindfulness neurostimulation for depression, UC San Diego

The National Library of Medicine registered a new clinical trial, NCT07512284, on ClinicalTrials.gov. The MEND II study will investigate mindfulness neurostimulation as an intervention for depression at UC San Diego.

Precision radiotherapy, molecular MRI, brain cancer, Johns Hopkins

The National Library of Medicine registered clinical trial NCT07512154 on ClinicalTrials.gov. The trial, sponsored by Johns Hopkins University, studies precision radiotherapy combined with molecular MRI for brain cancer. This registration fulfills requirements under 42 U.S.C. §282 for federally funded clinical trials to be publicly registered.

AML clinical trial investigating TP53 mutation treatment

The National Library of Medicine registered a new clinical trial on ClinicalTrials.gov (NCT07511062) investigating treatment for TP53 mutations in Acute Myeloid Leukemia (AML) patients. This is an informational registry entry providing public access to trial information as required under federal clinical trial registration requirements.

Sacituzumab tirumotecan Phase 2 anal/rectal cancer trial

The National Library of Medicine registered a new Phase 2 clinical trial (NCT07511023) on ClinicalTrials.gov evaluating sacituzumab tirumotecan for the treatment of anal and rectal cancer. The single-arm study will enroll participants with metastatic or locally advanced disease. This trial registration provides public transparency on an ongoing cancer immunotherapy study.

AZD1043 Safety Study - AstraZeneca/Parexel

The National Library of Medicine updated ClinicalTrials.gov to add a new Phase 1 safety study for AZD1043 sponsored by AstraZeneca and Parexel. The trial is listed as 'not recruiting.' Clinical investigators and pharmaceutical sponsors should ensure their trials are properly registered.

VDBD Treatment Clinical Trial NCT07513129

The National Library of Medicine registered clinical trial NCT07513129 on ClinicalTrials.gov to study VDBD treatment. The trial is now publicly accessible in the clinical trials database.

Venetoclax CACAG versus 3+7 regimen acute monocytic leukemia

The National Library of Medicine registered a new Phase 2 clinical trial (NCT07512700) on ClinicalTrials.gov investigating venetoclax-based CACAG regimen versus standard 3+7 chemotherapy for acute monocytic leukemia in adult patients. The trial is currently recruiting participants.

Lawyer Niche Focus Builds Expertise, Value Over Price

The American Bar Association published an informational article advising lawyers on practice development strategy. The article argues that lawyers who narrow their practice focus develop deeper expertise, attract higher-value clients, and avoid price competition compared to generalists. The article includes two self-assessment tests for evaluating current positioning.